A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 08 Nov 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Vorinostat (Primary) ; Carboplatin; Paclitaxel
Indications Anal cancer; Breast cancer; Gastric cancer; Head and neck cancer; Laryngeal cancer; Nasopharyngeal cancer; Non-small cell lung cancer; Oesophageal cancer; Oropharyngeal cancer; Ovarian cancer; Salivary gland cancer; Solid tumours; Squamous cell cancer
Focus Adverse reactions

23 Aug 2017 Status changed from active, no longer recruiting to discontinued due to inadequate accrual rate.
02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
11 Oct 2016 Planned End Date changed from 1 Jan 2021 to 1 Jan 2020.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com